84 F Clouds
Saturday, Nov 02 2024, 07:11 PM
Close Ad
Back To Listing

Limited supply of AstraZeneca vaccine now available

COVID - 19 30 Apr, 2021 Follow News

Limited supply of AstraZeneca vaccine now available

Public Health has received a very limited supply of the AstraZeneca vaccine available to persons who are unable to take the Pfizer vaccine due to medical reasons or otherwise prefer to take this vaccine.

The AstraZeneca vaccine will only be administered on Saturday May 1st and Monday May 3rd at the ORIA Vaccination Clinic. The first dose of the vaccine must be administered no later than Monday May 3rd to ensure the second dose is administered by its expiration date of May 31st 2021. AstraZeneca requires a 28-day interval between each dose. This vaccine has been approved for persons 18 years and older.

The AstraZeneca vaccine requires a consent form for Dose 1. Please click here or visit https://www.hsa.ky/public-health/coronavirus/ to download the consent form.

Please advise a member of Public Health staff if you are there to receive AstraZeneca.

COVID-19 vaccination clinic reminders:

AstraZeneca COVID vaccine is available to ALL persons 18 years and over.

Pfizer COVID vaccine is available to ALL persons 16 years and over (parental consent required for 16 & 17 year olds).

Photo ID showing date of birth is still required, however, persons no longer need to provide identification to demonstrate they are an ordinarily and legally resident

When receiving your 2nd dose, you MUST also bring along your vaccination card reflecting your 1st dose.

Do not laminate your vaccination card at any time. (If you have already done so, please bring your vaccination card to the ORIA Vaccination Clinic along with your photo ID.)

Park in the long-term parking lot.

Do not bring children, when possible.

No pets allowed at the vaccination clinic.

Facemasks required.

Persons 60 years and older will be given priority.

For the most up to date vaccination schedule visit https://hsa.ky/public-health/coronavirus/


Comments (0)

We appreciate your feedback. You can comment here with your pseudonym or real name. You can leave a comment with or without entering an email address. All comments will be reviewed before they are published.

* Denotes Required Inputs